Northwestern Mutual Wealth Management Co. Purchases 426,714 Shares of GE HealthCare Technologies Inc. $GEHC

Northwestern Mutual Wealth Management Co. lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2,978.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 441,039 shares of the company’s stock after buying an additional 426,714 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in GE HealthCare Technologies were worth $36,174,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after buying an additional 267,058 shares in the last quarter. Dodge & Cox boosted its position in GE HealthCare Technologies by 16.8% during the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock worth $2,066,550,000 after purchasing an additional 3,949,361 shares during the period. Capital Research Global Investors boosted its position in GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. Hotchkis & Wiley Capital Management LLC boosted its position in GE HealthCare Technologies by 17.1% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after purchasing an additional 1,232,828 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in GE HealthCare Technologies by 8.9% during the third quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company’s stock worth $402,647,000 after purchasing an additional 438,439 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Up 1.2%

GEHC stock opened at $61.51 on Tuesday. The company has a market cap of $27.98 billion, a PE ratio of 14.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.74. The business has a 50-day simple moving average of $69.27 and a 200 day simple moving average of $76.59. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the firm earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on GEHC shares. Weiss Ratings cut shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Citigroup reduced their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Evercore set a $80.00 price objective on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Finally, The Goldman Sachs Group cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $81.00 to $65.00 in a research report on Thursday, April 30th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $80.67.

Insiders Place Their Bets

In related news, Director Watkin Phoebe L. Yang purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was acquired at an average price of $63.01 per share, with a total value of $63,010.00. Following the completion of the purchase, the director directly owned 13,702 shares in the company, valued at $863,363.02. This trade represents a 7.87% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Frank R. Jimenez purchased 1,750 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average cost of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider owned 93,932 shares of the company’s stock, valued at $5,678,189.40. This represents a 1.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 11,847 shares of company stock valued at $719,555 over the last 90 days. 0.36% of the stock is owned by company insiders.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.